Cancer clinical trials in the region Bourgogne-Franche-Comté

155 currently recruiting clinical trials
Region Bourgogne-Franche-Comté

Phase 3 Colon cancer Rectal cancer #NCT02885753
Adenocarcinoma Metastatic None Systemic Treatment-Naive
Institut de Cancérologie de Bourgogne - Site de Dijon (Dijon), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre hospitalier universitaire François Mitterrand (Dijon), Centre Hospitalier William Morey (Chalon-sur-Saône), Centre Hospitalier Universitaire de Besançon (Besançon) (and 2 more...)
Fédération Francophone de Cancérologie Digestive
Phase 3 Colon cancer Rectal cancer #NCT06293625
Adenocarcinoma Locally Advanced MSS None Systemic Treatment-Naive
MSI/dMMR
Institut de Cancérologie de Bourgogne - Site de Dijon (Dijon), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre hospitalier universitaire François Mitterrand (Dijon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier d’Auxerre (Auxerre) (and 1 more...)
CHU Dijon
Phase 3 Stomach and esophageal cancer #NCT05078047
Stomach Oesogastric junction Esophagus Adenocarcinoma Squamous cell carcinoma Locally Advanced Metastatic Immunotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
UNICANCER
Phase 3 Pancreas cancer #NCT00268411
Adenocarcinoma Metastatic None Systemic Treatment-Naive
Chemotherapy Radiotherapy Chemotherapy Radiotherapy
Polyclinique du Parc Drevon - Ramsay Santé (Dijon)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 3 Stomach and esophageal cancer #NCT06346392
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 1 2 3 or more Chemotherapy
HER2 Systemic Treatment-Naive
Centre Hospitalier Universitaire de Besançon (Besançon)
AstraZeneca
Phase 3 Lung cancer #NCT05078047
Locally Advanced Metastatic Immunotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
UNICANCER
Phase 3 Breast cancer #NCT06393374
HER2 Negative HR Negative Localized Locally Advanced None Surgery Immunotherapy Chemotherapy Surgery Immunotherapy Chemotherapy
BRCA 1/2 Systemic Treatment-Naive Antibody Drug Conjugates (ADC) Systemic Treatment-Naive Antibody Drug Conjugates (ADC)
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Besançon (Besançon)
Merck Sharp & Dohme LLC
Phase 3 Breast cancer #NCT06018337
HER2 Low HR Positive Locally Advanced Metastatic 1 2 Targeted therapy Hormone therapy
Chemotherapy Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Besançon (Besançon)
DualityBio Inc.
Phase 3 Endometrial cancer #NCT05078047
Endometrioid adenocarcinoma Serous adenocarcinoma Clear cell carcinoma Dedifferentiated and undifferentiated endometrial ... Locally Advanced Metastatic Immunotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
UNICANCER
Phase 3 Prostate cancer #NCT06625970
Adenocarcinoma Localized PSMA PET Negative None Systemic Treatment-Naive
Surgery Radiotherapy Internal Vectorised Radiotherapy (IVR)
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
UNICANCER